334 related articles for article (PubMed ID: 17430164)
21. Statin therapy for vascular failure.
Inoue T; Node K
Cardiovasc Drugs Ther; 2007 Aug; 21(4):281-95. PubMed ID: 17682928
[TBL] [Abstract][Full Text] [Related]
22. [Do the pleiotropic effects of statins have a clinical significance?].
Vergès B
Arch Mal Coeur Vaiss; 2004 Dec; 97(12):1231-5. PubMed ID: 15669365
[TBL] [Abstract][Full Text] [Related]
23. Ongoing clinical trials of the pleiotropic effects of statins.
Davignon J; Leiter LA
Vasc Health Risk Manag; 2005; 1(1):29-40. PubMed ID: 17319096
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms of acute coronary syndromes and the potential role of statins.
Dupuis J
Atheroscler Suppl; 2001 Feb; 2(1):9-14. PubMed ID: 11286155
[TBL] [Abstract][Full Text] [Related]
25. Do we know enough about the immune pathogenesis of acute coronary syndromes to improve clinical practice?
Matusik P; Guzik B; Weber C; Guzik TJ
Thromb Haemost; 2012 Sep; 108(3):443-56. PubMed ID: 22872109
[TBL] [Abstract][Full Text] [Related]
26. Cardiovascular protection by anti-inflammatory statin therapy.
Howard-Alpe G; Foëx P; Biccard B
Best Pract Res Clin Anaesthesiol; 2008 Mar; 22(1):111-33. PubMed ID: 18494392
[TBL] [Abstract][Full Text] [Related]
27. Atherosclerosis: anti-inflammatory and immunomodulatory activities of statins.
Kwak BR; Mulhaupt F; Mach F
Autoimmun Rev; 2003 Oct; 2(6):332-8. PubMed ID: 14550874
[TBL] [Abstract][Full Text] [Related]
28. Statin-associated pleiotropy: possible beneficial effects beyond cholesterol reduction.
Ito MK; Talbert RL; Tsimikas S
Pharmacotherapy; 2006 Jul; 26(7 Pt 2):85S-97S; discussion 98S-101S; quiz 106S-108S. PubMed ID: 16803418
[TBL] [Abstract][Full Text] [Related]
29. Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk.
Robinson JG
Am J Cardiol; 2008 Apr; 101(7):1009-15. PubMed ID: 18359323
[TBL] [Abstract][Full Text] [Related]
30. Statins reduce vascular inflammation in atherogenesis: A review of underlying molecular mechanisms.
Liberale L; Carbone F; Montecucco F; Sahebkar A
Int J Biochem Cell Biol; 2020 May; 122():105735. PubMed ID: 32126319
[TBL] [Abstract][Full Text] [Related]
31. Progression and Characterization of the Accelerated Atherosclerosis in Iliac Artery of New Zealand White Rabbits: Effect of Simvastatin.
Kanshana JS; Khanna V; Singh V; Jain M; Misra A; Kumar S; Farooqui M; Barthwal MK; Dikshit M
J Cardiovasc Pharmacol; 2017 May; 69(5):314-325. PubMed ID: 28207427
[TBL] [Abstract][Full Text] [Related]
32. Beneficial cardiovascular pleiotropic effects of statins.
Davignon J
Circulation; 2004 Jun; 109(23 Suppl 1):III39-43. PubMed ID: 15198965
[TBL] [Abstract][Full Text] [Related]
33. Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander?
Nordestgaard BG; Zacho J
Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):521-4. PubMed ID: 19695857
[TBL] [Abstract][Full Text] [Related]
34. Pleiotropic effects of statins--clinical evidence.
Athyros VG; Kakafika AI; Tziomalos K; Karagiannis A; Mikhailidis DP
Curr Pharm Des; 2009; 15(5):479-89. PubMed ID: 19199976
[TBL] [Abstract][Full Text] [Related]
35. Effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition on serum matrix metalloproteinase-13 and tissue inhibitor matrix metalloproteinase-1 levels as a sign of plaque stabilization.
Cevik C; Otahbachi M; Nugent K; Warangkana C; Meyerrose G
J Cardiovasc Med (Hagerstown); 2008 Dec; 9(12):1274-8. PubMed ID: 19001938
[TBL] [Abstract][Full Text] [Related]
36. Pleiotropic effects of statins.
Liao JK; Laufs U
Annu Rev Pharmacol Toxicol; 2005; 45():89-118. PubMed ID: 15822172
[TBL] [Abstract][Full Text] [Related]
37. Pleiotropic effects: should statins be considered an essential component in the treatment of dyslipidemia?
Mays ME; Dujovne CA
Curr Atheroscler Rep; 2008 Feb; 10(1):45-52. PubMed ID: 18366985
[TBL] [Abstract][Full Text] [Related]
38. mTOR inhibition: a promising strategy for stabilization of atherosclerotic plaques.
Martinet W; De Loof H; De Meyer GRY
Atherosclerosis; 2014 Apr; 233(2):601-607. PubMed ID: 24534455
[TBL] [Abstract][Full Text] [Related]
39. Pitavastatin: an overview.
Saito Y
Atheroscler Suppl; 2011 Nov; 12(3):271-6. PubMed ID: 22152281
[TBL] [Abstract][Full Text] [Related]
40. [The promise of statins].
Capurso A
Ital Heart J Suppl; 2001 Mar; 2(3):224-9. PubMed ID: 11307780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
